Entity family

Browse funders

Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.

1articles mentioning funders

1funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: NCT02484404 ×

NCT02484404

This funder is selected. Its supporting articles are shown below.

NCT024844041

Articles mentioning NCT02484404

1 articles · page 1 of 1

Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancer

jitc · abstract · 2026-03-25 · 1 matching annotations

76.1%

NCT02484404 durvalumab olaparib abiraterone enzalutamide advanced prostate cancer mCRPC metastatic castration-resistant prostate cancer

…e for combination approaches in mCRPC.Trial registration number NCT02484404.…